Isaura Santos,  —

https://sclerodermanews.com/wp-content/uploads/videos/Sequence04.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Dr. Mihaela Ianosev, GlaxoSmithKline. Follow our live coverage of #SSc16 on Twitter and here: http://bit.ly/1Ts2X9H…

https://sclerodermanews.com/wp-content/uploads/videos/Entrevista02.mp4 Scleroderma News correspondent Dr. Ana de Barros conducts an exclusive interview with Dr. Colin Meyer, Reata Pharmaceuticals. Follow our live coverage of #SSc16 on Twitter and here: http://bit.ly/1Ts2X9H…

In this video from the Scleroderma Foundation, learn from Dinesh Khanna, MD, MS, about the gut involvement (also called digestive system or gastrointestinal involvement) in scleroderma and how it can affect up to 95 percent of people suffering from the disease. This lecture from the 2015 Scleroderma Foundation National…

Three leading organizations focused on scleroderma advocacy and research are partnering during June’s Scleroderma Awareness Month in order to boost awareness and compassion for those who suffer from the disease and their families. The Scleroderma Foundation, Scleroderma Research Foundation and Scleroderma Society of Canada are the primary partners in the effort. This…

Bob Saget will once again host the 34th Cool Comedy – Hot Cuisine gala to benefit the Scleroderma Research Foundation (SRF). It will be held on Friday, June 5 at the Four Seasons Beverly Wilshire. Saget, who lost his sister to scleroderma and currently serves as an SRF Board Member, will appear along with friends and…

Fibrocell Science, Inc., an autologous gene and cell therapy firm developing first-in-class treatments to address scleroderma and connective tissue-related diseases, recently announced that the United States Food and Drug Administration (FDA) has awarded a rare pediatric disease designation for FCX-007. This is the Fibrocell’s main orphan gene-therapy drug candidate to treat recessive dystrophic epidermolysis bullosa…

The Strategic Pharma-Academic Research Consortium for Translational Medicine has announced it is providing new grants that will support research into autoimmune diseases worth $1.9 million in total. The consortium is led by the Indiana Clinical and Translational Sciences Institute and is offering financial support for research projects involving scleroderma, dermatomyositis, lupus, multiple sclerosis and Crohn’s disease. Other…

Fibrocell Science, Inc., a company focused on autologous cell and gene therapy that is developing top treatments to address rare and life-threatening skin and connective tissue illnesses, has announced that it will report its first quarter 2015 results next Friday, May 8, 2015. The report will be made available to the public before the United States financial markets…

Cytori Therapeutics, Inc. recently announced an FDA approval that will allow them to expand the number of sites in the United States from 12 to 20 centers where the company’s Scleroderma clinical trials are currently being conducted. The STAR study was approved by the FDA in January 2015 as an 80-patient…

Cytori Therapeutics, Inc. recently announced that the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has given a positive opinion concerning Cytori’s submission for an orphan drug designation for ECCS-50, the company’s experimental Scleroderma therapeutic, which is based on stromal vascular fraction cells, from adipose tissue and derived from Celution® System,…